Judge: Corepharma Did Not Infringe Carbatrol Patent
Following a protracted battle over whether a patent related to Shire Laboratories Inc.'s anti-seizure drug Carbatrol should be included in a suit contesting a generic version of the medication, a federal...To view the full article, register now.
Already a subscriber? Click here to view full article